BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15463889)

  • 21. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
    Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
    J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
    Maclayton DO; Hall RG
    Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan.
    Kohno S; Yamaguchi K; Aikawa N; Sumiyama Y; Odagiri S; Aoki N; Niki Y; Watanabe S; Furue M; Ito T; Croos-Dabrera R; Tack KJ
    J Antimicrob Chemother; 2007 Dec; 60(6):1361-9. PubMed ID: 17913720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Empiric antibiotic therapy for acute osteoarticular infections with suspected methicillin-resistant Staphylococcus aureus or Kingella.
    Saphyakhajon P; Joshi AY; Huskins WC; Henry NK; Boyce TG
    Pediatr Infect Dis J; 2008 Aug; 27(8):765-7. PubMed ID: 18600193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of linezolid resistance in a methicillin resistant Staphylococcus aureus strain.
    Hentschke M; Saager B; Horstkotte MA; Scherpe S; Wolters M; Kabisch H; Grosse R; Heisig P; Aepfelbacher M; Rohde H
    Infection; 2008 Feb; 36(1):85-7. PubMed ID: 18165857
    [No Abstract]   [Full Text] [Related]  

  • 26. Successful treatment of meningoencephalitis caused by methicillin-resistant Staphylococcus aureus with intravenous linezolid in an allogeneic cord blood stem cell transplant recipient.
    Higa T; Tasaka T; Kubo Y; Nakagiri I; Sano F; Matsuhashi Y; Fukai Y; Wada H; Tohyama K; Sugihara T
    Scand J Infect Dis; 2008; 40(11-12):990-2. PubMed ID: 18651266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of linezolid in children with cystic fibrosis.
    Santos RP; Prestidge CB; Brown ME; Urbancyzk B; Murphey DK; Salvatore CM; Jafri HS; McCracken GH; Ahmad N; Sanchez PJ; Siegel JD
    Pediatr Pulmonol; 2009 Feb; 44(2):148-54. PubMed ID: 19137597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of MRSA native valve endocarditis with oral linezolid therapy: a case report.
    Nathani N; Iles P; Elliott TS
    J Infect; 2005 Nov; 51(4):e213-5. PubMed ID: 16291272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome.
    Ruhe JJ; Smith N; Bradsher RW; Menon A
    Clin Infect Dis; 2007 Mar; 44(6):777-84. PubMed ID: 17304447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment failure of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
    Corne P; Marchandin H; Macia JC; Jonquet O
    Scand J Infect Dis; 2005; 37(11-12):946-9. PubMed ID: 16308242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linezolid versus cefadroxil in the treatment of skin and skin structure infections in children.
    Wible K; Tregnaghi M; Bruss J; Fleishaker D; Naberhuis-Stehouwer S; Hilty M
    Pediatr Infect Dis J; 2003 Apr; 22(4):315-23. PubMed ID: 12690270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occurrence of MRSA endocarditis during linezolid treatment.
    Ben Mansour EH; Jacob E; Monchi M; Ledoux D; Canivet JL; De Mol P; Damas P
    Eur J Clin Microbiol Infect Dis; 2003 Jun; 22(6):372-3. PubMed ID: 12768433
    [No Abstract]   [Full Text] [Related]  

  • 33. Successful treatment with linezolid of septic shock secondary to methicillin-resistant Staphylococcus aureus arthritis.
    De Bels D; Garcia-Filoso A; Jeanmaire M; Préseau T; Miendje Deyi VY; Devriendt J
    J Antimicrob Chemother; 2005 May; 55(5):812-3. PubMed ID: 15743893
    [No Abstract]   [Full Text] [Related]  

  • 34. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
    Steinkraus G; White R; Friedrich L
    J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation.
    Miller LG; Perdreau-Remington F; Bayer AS; Diep B; Tan N; Bharadwa K; Tsui J; Perlroth J; Shay A; Tagudar G; Ibebuogu U; Spellberg B
    Clin Infect Dis; 2007 Feb; 44(4):471-82. PubMed ID: 17243048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A holistic approach to MRSA eradication in critically ill patients with MRSA pneumonia.
    Wenisch C; Laferl H; Szell M; Smolle KH; Grisold A; Bertha G; Krause R
    Infection; 2006 Jun; 34(3):148-54. PubMed ID: 16804658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methicillin-resistant Staphylococcus aureus endocarditis in an extremely low-birth-weight infant treated with linezolid.
    Sung TJ; Kim HM; Kim MJ
    Clin Pediatr (Phila); 2008 Jun; 47(5):504-6. PubMed ID: 18509151
    [No Abstract]   [Full Text] [Related]  

  • 38. Methicillin-resistant Staphylococcus aureus infections in children.
    Swanson DS
    Mo Med; 2006; 103(1):77-80. PubMed ID: 16579310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of refractory deep incisional surgical site infection due to methicillin-resistant Staphylococcus aureus (MRSA) and successfully treated with oral linezolid].
    Matsumoto H; Kawabata R; Kishimoto T; Yamamoto E; Kimura Y; Imamura H; Yamamoto T; Takemoto H; Fukunaga M; Ohzato H
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2441-3. PubMed ID: 23268104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
    Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.